Literature DB >> 26035816

Outcome of HIV-infected Pregnant Women and Their Offspring in Barbados: A Five-year Study.

M A St John1, F Denny2, D Babb2.   

Abstract

OBJECTIVES: To describe the outcome of HIV-infected pregnant women and their offspring during a five-year period.
METHODS: The medical records of HIV-infected pregnant women who delivered between January 2007 and December 2011 and their HIV-exposed infants were reviewed. Demographics, outcome of pregnancy and infants, and clinic attendance were analysed. Data were entered on a Microsoft Excel spreadsheet.
RESULTS: One hundred and forty-three women, aged 17-45 years (mean 27.3 years), were included in the study with 143 pregnancies and 142 pregnancy outcomes being recorded. One woman migrated before delivery. There were 122 live births and 18 (13%) terminations: 13 (9%) elective and five (4%) spontaneous. There was one ectopic pregnancy and one stillbirth. One hundred and twenty-two (85%) women were unmarried. Women were prescribed highly active antiretroviral therapy for prevention of mother-to-child transmission from the time of booking, apart from those opting for terminations or those who had spontaneous abortions. For clinic follow-up, 105 (73%) had regular attendance, 30 (21%) defaulted and could not be located despite intense tracking, four attended irregularly, and one refused to attend clinic. Four (3%) migrated after delivery. Two (1%) mothers died during the period of study. Two successive DNA polymerase chain reaction tests done within four months of age did not substantiate any cases of infant infection.
CONCLUSION: This study revealed that there was a good outcome and compliance with follow-up of HIV-infected pregnant women and their offspring.

Entities:  

Year:  2015        PMID: 26035816      PMCID: PMC4696614          DOI: 10.7727/wimj.2015.109

Source DB:  PubMed          Journal:  West Indian Med J        ISSN: 0043-3144            Impact factor:   0.171


  4 in total

1.  Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial.

Authors:  R Nduati; G John; D Mbori-Ngacha; B Richardson; J Overbaugh; A Mwatha; J Ndinya-Achola; J Bwayo; F E Onyango; J Hughes; J Kreiss
Journal:  JAMA       Date:  2000-03-01       Impact factor: 56.272

2.  Risk of human immunodeficiency virus type 1 transmission through breastfeeding.

Authors:  D T Dunn; M L Newell; A E Ades; C S Peckham
Journal:  Lancet       Date:  1992-09-05       Impact factor: 79.321

3.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  E M Connor; R S Sperling; R Gelber; P Kiselev; G Scott; M J O'Sullivan; R VanDyke; M Bey; W Shearer; R L Jacobson
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

4.  Reduction in perinatal transmission and mortality from human immunodeficiency virus after intervention with zidovudine in Barbados.

Authors:  Anne M St John; Alok Kumar; Clyde Cave
Journal:  Pediatr Infect Dis J       Date:  2003-05       Impact factor: 2.129

  4 in total
  1 in total

1.  A New Strategy to Increase Scientific Publications and Facilitate Research Uptake in the Caribbean.

Authors:  D T Simeon
Journal:  West Indian Med J       Date:  2015-01       Impact factor: 0.171

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.